Theranostics 2021; 11(20):9918-9936. doi:10.7150/thno.66378 This issue Cite

Research Paper

CRTC3, a sensor and key regulator for melanogenesis, as a tunable therapeutic target for pigmentary disorders

Hanju Yoo1,3#, Ha-Ri Lee2,3#, Ki-Hyun Kim2,3, Min-Ah Kim2,3, Seunghyun Bang1,3, Young-Ho Kang2,3, Woo-hyung Kim1,3, Youngsup Song2,3 ✉, Sung Eun Chang1,3✉

1. Department of Dermatology, University of Ulsan College of Medicine, Seoul, 05505, Korea.
2. Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul, 05505, Korea.
3. Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Korea.
#These authors contributed equally to this work.

Citation:
Yoo H, Lee HR, Kim KH, Kim MA, Bang S, Kang YH, Kim Wh, Song Y, Chang SE. CRTC3, a sensor and key regulator for melanogenesis, as a tunable therapeutic target for pigmentary disorders. Theranostics 2021; 11(20):9918-9936. doi:10.7150/thno.66378. https://www.thno.org/v11p9918.htm
Other styles

File import instruction

Abstract

Graphic abstract

Background: Although CREB phosphorylation is known to be essential in UVB/cAMP-stimulated melanogenesis, CREB null mice did not show identifiable pigmentation phenotypes. Here, we show that CREB-regulated transcription co-activator 3 (CRTC3) quantitatively regulates and orchestrates melanogenesis by directly targeting microphthalmia-associated transcription factor (MITF) and regulating the expression of most key melanogenesis-related genes.

Methods: We analyzed CRTC3-null, KRT14-SCF transgenic, and their crossover mice. The molecular basis of CRTC3 effects on pigmentation was investigated by histology, melanin/tyrosinase assay, immunoblotting, shRNA, promoter assay, qRT-PCR, and subcellular localization. These analyses were carried out in primary cultured melanocytes, mouse cell lines, normal human cells, co-cultures, and ex vivo human skin. CRTC/CREB activity screening was performed to identify candidate agents for the regulation of melanogenesis.

Results: The coat and skin color of CRTC3-null mice was paler due to a reduction in melanin deposition. Melanogenesis-related genes were reduced in CRTC3-deficient cultured melanocytes and tail skin of CRTC3-null mice. Notably, basal levels of MITF present in CRTC3-null mice were sufficient for melanocytic differentiation/survival. Thus CRTC3-null mice showed a comparable number of epidermal melanocytes compared to control mice. Stem cell factor (SCF) introduction by crossing with KRT14-SCF mice increased epidermal melanocytes and melanin deposition in control and CRTC3-null mice, but the skin color remained still light on the CRTC3-null background. Furthermore, we identified the therapeutic potential of altiratinib to inhibit melanogenesis in human melanocytes and human skin effectively and safely.

Conclusion: CRTC3 appears to be a key sensor for melanogenesis and can be used as a reversible and tunable tool for selectively regulating melanogenesis without affecting melanocyte integrity. Thus, CRTC3 can also serve as a screening tool for the discovery of ideal melanogenesis-modulating small molecules.

Keywords: cAMP- or UV-stimulated melanogenesis, CRTC3/CREB, MITF, melanocytes


Citation styles

APA
Yoo, H., Lee, H.R., Kim, K.H., Kim, M.A., Bang, S., Kang, Y.H., Kim, W.h., Song, Y., Chang, S.E. (2021). CRTC3, a sensor and key regulator for melanogenesis, as a tunable therapeutic target for pigmentary disorders. Theranostics, 11(20), 9918-9936. https://doi.org/10.7150/thno.66378.

ACS
Yoo, H.; Lee, H.R.; Kim, K.H.; Kim, M.A.; Bang, S.; Kang, Y.H.; Kim, W.h.; Song, Y.; Chang, S.E. CRTC3, a sensor and key regulator for melanogenesis, as a tunable therapeutic target for pigmentary disorders. Theranostics 2021, 11 (20), 9918-9936. DOI: 10.7150/thno.66378.

NLM
Yoo H, Lee HR, Kim KH, Kim MA, Bang S, Kang YH, Kim Wh, Song Y, Chang SE. CRTC3, a sensor and key regulator for melanogenesis, as a tunable therapeutic target for pigmentary disorders. Theranostics 2021; 11(20):9918-9936. doi:10.7150/thno.66378. https://www.thno.org/v11p9918.htm

CSE
Yoo H, Lee HR, Kim KH, Kim MA, Bang S, Kang YH, Kim Wh, Song Y, Chang SE. 2021. CRTC3, a sensor and key regulator for melanogenesis, as a tunable therapeutic target for pigmentary disorders. Theranostics. 11(20):9918-9936.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.